Fate of cancerostatic platinum compounds in biological wastewater treatment of hospital effluents

Chemosphere

Volumn 69, Issue 11, 2007, Pages 1765-1774

  Lenz, Katharina ^a   Koellensperger, Gunda ^a   Hann, Stephan ^a   Weissenbacher, Norbert ^a   Mahnik, Susanne N ^a   Fuerhacker, Maria ^a  

^a UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES   (Austria)

Author keywords

Activated sludge; Adsorption; Cancerostatic platinum compounds; Hospital wastewater

Indexed keywords

ACTIVATED SLUDGE PROCESS; ADSORPTION; BIOREACTORS; CONCENTRATION (PROCESS); EFFLUENTS; PLATINUM;

CANCEROSTATIC PLATINUM COMPOUNDS; HOSPITAL WASTEWATER; MONITORING PERIODS;

WASTEWATER TREATMENT;

CARBOPLATIN; CISPLATIN; PLATINUM DERIVATIVE;

ACTIVATED SLUDGE PROCESS; ADSORPTION; BIOREACTORS; CONCENTRATION (PROCESS); EFFLUENTS; PLATINUM; WASTEWATER TREATMENT;

ACTIVATED SLUDGE; ADSORPTION; BIOREACTOR; EFFLUENT; MEMBRANE; PLATINUM; WASTE TREATMENT; WASTEWATER;

ADSORPTION; ARTICLE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; WASTE WATER MANAGEMENT;

EID: 35448957704     PISSN: 00456535     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chemosphere.2007.05.062     Document Type: Article

References (30)

1. Allen J., Graham M.A., Firth J., Woolfrey S., Greenslade D., and Morrison J.G. Biotransformation and pharmacokinetic analysis of oxaliplatin in patients with advanced gastrointestinal cancer. P. Am. Assoc. Canc. Res. 39 (1998) 159
2. Clara M., Strenn B., Saracevic E., and Kreuzinger N. The solids retention time - a suitable design parameter to evaluate the capacity of wastewater treatment plants to remove micropollutants. Water Res. 39 (2005) 97-106
3. Council Directive (76/464/EWG) 2000, Amt für amtliche Veröffentlichungen der Europäischen Union. CONSLEG: 1976L0464 - 22/12/2000, , May 2006.
4. Council Directive (80/68/EWG) 1991, Amt für amtliche Veröffentlichungen der Europäischen Union. CONSLEG: 1980L0068 - 23/12/1991, , May 2006.
5. Desoize B., and Madoulet C. Particular aspects of platinum compounds used at present in cancer treatment. Crit. Rev. Oncol. Hemat. 42 (2002) 317-325
6. DEV 2003. Deutsche Einheitsverfahren zur Wasser-, Abwasser- und Schlammuntersuchung. Physikalische, chemische, biologische und bakteriologische Verfahren, 56th edition. Weinheim: Wasserchemische Gesellschaft - Fachgruppe in der Gesellschaft Deutscher Chemiker in Gemeinschaft mit dem Normenausschuss Wasserwesen (NAW) im DIN Deutscher Institute für Normung.
7. Elferink F., Van der Vijgh W.J., Klein I., Vermorken J.B., Gall H.E., and Pinedo H.M. Pharmacokinetics of carboplatin after IV administration. Cancer Treat. Rep. 71 (1987) 1231-1237
8. EURACHEM/CITAC Guide CG 4, 2000. Quantifying Uncertainty in Analytical Measurement. Second edition, ISBN 0 948926 15 5, EURACHEM/CITAC, London.
9. European Commission, 2000. Water Framework Directive (Directive 2000/60/EC). .
10. Fuerhacker, M., Lenz, K., Mahnik, S., Weissenbacher, N., Mader, R., Knasmueller, S., Ferk, F., Uhl, M. Bursch, W., Koellensperger, G., Hann, S., 2006. Chemische Analyse, Risikobewertung und Entfernung von ausgewählten Zytostatika aus Abwasserströmen aus Krankenhäusern. Research Report. Austrian Federal Ministry of Agriculture, Forestry, Environment and Water Management.
11. Gebel T. Toxicology of platinum, palladium and rhodium, and their compounds. In: Zereini F., and Alt F. (Eds). Anthropogenic Platinum Group Element Emissions (2000), Springer, Berlin, Heidelberg, New York 227-237
12. Graham M.A., Gamelin E., Misset J.L., Brienza S., Allain P., Boisdron-Celle M., Krikorian A., Greenslade D., and Bayssas M. Clinical pharmacokinetics of oxaliplatin. P. Am. Assoc. Canc. Res 39 (1998) 159
13. Graham M.A., Lockwood G.F., Greenslade D., Brienza S., Bayssas M., and Gamelin E. Clinical pharmacokinetics of oxaliplatin: A critical review. Clin. Cancer Res. 6 (2000) 1205-1218
14. Hann S., Koellensperger G., Stefánka Zs., Stingeder G., Fuerhacker M., Buchberger W., and Mader R.M. Application of HPLC-ICP-MS to speciation of cisplatin and its degradation products in water containing different chloride concentrations and in human urine. J. Anal. Atom. Spectrom. 18 (2003) 1391-1395
15. Hann S., Stefánka Zs., Lenz K., and Stingeder G. Novel separation method for highly sensitive speciation of platinum compounds by HPLC-ICP-MS. Anal. Bioanal. Chem. 381 (2005) 405-412
16. IARC-International Agency for Research on Cancer, 1987. Monographs on the Evaluation of Cancerogenic Risks to Humans. Suppl. 7, Lyon.
17. Kuemmerer K., and Helmers E. Hospital effluents as a source for platinum in the environment. Sci. Total Environ. 193 (1997) 179-184
18. Lenz K., Hann S., Koellensperger G., Stefánka Zs., Stingeder G., Weissenbacher N., Mahnik S.N., and Fuerhacker M. Monitoring and elimination of cancerostatic platinum compounds present in hospital effluents. Sci. Total. Environ. 345 (2005) 141-152
19. Lenz K., Koellensperger G., Fuerhacker M., Stingeder G., and Hann S. Desorption of cancerostatic platinum compounds from solid phases in sewage treatment. Gesellschaft für Mineralstoffe und Spurenelemente, Schriftenreihe Spurenelemente (2005), Wissenschafts Verlag, Stuttgart
20. Luo F.R., Yen T.Y., Wyrick S.D., and Chaney S.G. High-performance liquid chromatographic separation of the biotransformation products of oxaliplatin. J. Chromatogr. B 724 (1999) 345-356
21. Mahnik S., Mader R.M., and Fuerhacker M. Cytostatics in wastewater. Wiener Mitteilungen 178 (2002) 91-111
22. Miller S.E., and House D.A. The hydrolysis products of cis-dichlorodiammineplatinum(II) 1. The kinetics of formation and anation of the cis-Diamminedi(aqua)platinum(II) cation in acidic aqueous solution. Inorg. Chim. Acta 161 (1989) 131-137
23. Miller S.E., and House D.A. The hydrolysis products of cis-dichlorodiammineplatinum(II) 2. The kinetics of formation and anation of the cis-Diamminedi(aqua)platinum(II) cation. Inorg. Chim. Acta 166 (1989) 189-197
24. Miller S.E., and House D.A. The hydrolysis products of cis-dichlorodiammineplatinum(II) 3. Hydrolysis kinetics at physiological pH. Inorg. Chim. Acta 173 (1990) 53-60
25. OECD/OCDE 106, 2000. OECD Guideline for the testing of chemicals: Adsorption - Desorption using a Batch Equilibrium Method.
26. Roberts J.J., and Thomson A.J. The mechanism of action of antitumor platinum compounds. Progr. Nucl. Acid Re. 22 (1979) 71-133
27. Stefánka, Zs., Hann, S., Lenz, K., Koellensperger, G., Fuerhacker, M., Stingeder, G., 2004. Platinum speciation for environmental and biological analysis of cancerostatic platinum compounds. In: Holland, G. (Ed.), 9th International Conference on Plasma Source Mass Spectrometry, 12 September-17 September 2004, Durham, UK.
28. Tang X., Hayes II J.W., Schroder L., Cacini W., Dorsey J., Elder R.C., and Tepperman K. Determination of biotransformation products of platinum drugs in rat and human urine. Met. Based Drugs 4 (1997) 97-109
29. Vermorken V.B., Van der Vijgh W.J., Klein I., Hart A.A., Gall H.E., and Pinedo H.M. Pharmacokinetics of free and total platinum species after short-term infusion of cisplatin. Cancer Treat. Rep. 68 (1984) 503-513
30. Weissenbacher, N., Lenz, K., Mahnik, S., Hann, S., Koellensperger, G., Mader, R., Fuerhacker, M., 2005. Optimierung der Elimination ausgewählter Zytostatika mittels eines Membranbioreaktors. In: RWTH Aachen, editor. Proceedings of the 6th Aachener Tagung Siedlungswasserwirtschaft und Verfahrenstechnik: Membrantechnik; 25 October-26 October 2005, Aachen, Germany, 2005; A23.